Guardian Pharmacy Services (GRDN) Asset Writedowns and Impairment (2023 - 2026)

Guardian Pharmacy Services has reported Asset Writedowns and Impairment for 4 years, with the latest figure at $1.1 million in Q1 2026.

• Quarterly Asset Writedowns and Impairment rose 18.53% year-over-year to $1.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $4.7 million (down 19.14% YoY) and the FY2025 annual result came in at $4.6 million, down 28.08% from the prior year.
• Asset Writedowns and Impairment eased to $1.1 million in Q1 2026 per GRDN's latest filing, from $1.5 million in the prior quarter.
• Over five years, Asset Writedowns and Impairment peaked at $2.1 million in Q4 2024 and troughed at $896000.0 in Q1 2025.
• A 4-year average of $1.3 million and a median of $1.3 million in 2023 frame the typical range for Asset Writedowns and Impairment.
• The sharpest annual moves came in 2024 and 2025: Asset Writedowns and Impairment surged 56.27% in 2024, then sank 42.0% in 2025.
• Over 4 years, Asset Writedowns and Impairment stood at $1.4 million in 2023, then soared by 56.27% to $2.1 million in 2024, then plunged by 30.94% to $1.5 million in 2025, then declined by 27.8% to $1.1 million in 2026.
• According to Business Quant data, Asset Writedowns and Impairment over the past three periods registered $1.1 million, $1.5 million, and $1.2 million for Q1 2026, Q4 2025, and Q3 2025 respectively.